Value of cystatin C for Kawasaki disease with coronary artery aneurysm

Kaizhi Liang1, Danyan Su1, Yusheng Pang1

  • 1Department of Pediatrics, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.

PubMed

Insights

Elevated cystatin C levels before intravenous immunoglobulin treatment may predict coronary artery aneurysm in Kawasaki disease. Early cystatin C measurements show promise for identifying patients at higher risk.

Area of Science:

  • Pediatric Cardiology
  • Nephrology
  • Rheumatology

Background:

  • Cardiovascular and kidney diseases share biological pathways.
  • Renal function in Kawasaki disease (KD) requires further investigation.
  • Coronary artery aneurysm (CAA) is a severe cardiac complication of KD.

Purpose of the Study:

  • To evaluate cystatin C (Cys C) and other laboratory markers for predicting CAA in KD patients.
  • To assess the predictive value of Cys C before and after intravenous immunoglobulin (IVIG) treatment.
  • To identify independent risk factors for CAA development in KD.

Main Methods:

  • Retrospective analysis of 122 KD patients categorized by coronary status.
  • Multivariate logistic regression to identify independent risk factors for CAA.
  • Receiver operating characteristic (ROC) curves to assess predictive values of parameters.

Main Results:

  • 23% of KD patients developed CAA; 9.8% showed coronary artery regression.
  • Pre-IVIG Cys C was identified as an independent risk factor for CAA (OR=10.183).
  • A Cys C cut-off value of 0.71 within five days showed 100% sensitivity for CAA prediction (AUC=0.752).

Conclusions:

  • Higher pre-IVIG Cys C levels are associated with increased CAA risk in KD.
  • Early Cys C measurement (within five days) may enhance prediction of CAA development.
  • Further large-scale prospective studies are needed to confirm Cys C's predictive utility.
Abstract